According to the report, the global STD diagnostic market accounted for approximately USD 103.20 billion in 2015 and is expected to reach around USD 166.50 by 2021, growing at a CAGR of around 8.3% between 2015 and 2021. The term ‘Sexually Transmitted Diseases’ refers to a group of illnesses that can be transmitted from one person to another through the sharing of body fluids, vaginal fluids, blood, and others. The term sexually transmitted disease include more than 25-30 infectious diseases that are spread through sexual activity. Most people with STDs have no symptoms. Without treatment, these diseases can lead to major health problems such as not being able to get pregnant (infertility), permanent brain damage, heart disease, cancer, and even death. If patient has been exposed to a sexually transmitted disease he should visit a health clinic, hospital or doctor for testing and treatment. Common sexual transmitted diseases include chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus and others.
[wptab name=’Report Description’ active=”1″ ]
According to the report, the global STD diagnostic market accounted for approximately USD 103.20 billion in 2015 and is expected to reach around USD 166.50 by 2021, growing at a CAGR of around 8.3% between 2015 and 2021.
The term sexually transmitted diseases or STD are commonly used to refer to clinical syndromes and infectious diseases caused by pathogens that can be acquired and transmitted through sexual activity. These infections can easily spread by vaginal or anal intercourse, and sometimes by oral sex. STDs can also spread from the blood of infected patients. In addition, pregnant women with STD’s may pass their infection to infants in the uterus (womb), during birth, or through breast-feeding. Prevention of STD infection is possible by having protective sex (using condoms) or abstaining from the sex.
Globally, STD diagnostics market has been accelerated by the rise in the percentage of unprotected sex which leads to increase in the prevalence of sexually transmitted diseases. Furthermore, lack of awareness coupled with unprotected sex is considered as major governing factors which promote the cause of sexually transmitted diseases and thus STD diagnostic market. Moreover, many lifestyle-related factors, such as having multiple sex partners are estimated to drive the sexual transmitted diseases diagnostic market. However, lack of education, psychological impact and the unwillingness of the infected population to undergo prognosis is expected to hinder the growth of the market. In addition, prevention of infection by vaccination is major restraining factor in a growth of STDs diagnostic market.
Based on the type, the global market of STD diagnostic test is bifurcated into seven types: chlamydia testing, syphilis testing, gonorrhea testing, herpes simplex virus testing, human papiloma virus testing, human immunodeficiency virus testing and others. Global HIV diagnostics market size was approximately USD 2.77 billion in 2015, with a CAGR of 9.5% during the forecast period. The PAP smear tests segment accounted for the largest share of approximately more than 50% of the total HPV testing market in 2015. Factors attributed to its growth due to its lower test prices and growing awareness about the cancer diagnosis. Similarly, the HPV testing market is forecast to grow at the fastest growth rate of approximately more than 9% from 2015 to 2021.
Based on end-user, the global market for STD diagnostic test is bifurcated into two types: hospital and others. In end-user segment, the hospital was the leading segment in 2015 and this segment will remain in continuous growth during the forecast period due to the continuous rise in HPV virus across the globe.
Based on the testing device, the global market for STD diagnostic test is segmented into two major types: laboratory testing device and point of care device. The laboratory testing device market is further sub-segmented into thermal cyclers – PCR, lateral flow readers – immunochromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate reader – Enzyme Linked Immunosorbent Assay (ELISA) and others
Based on geographies, the global market for STD diagnostic is bifurcated into five types: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These segments are further bifurcated into the U.S., UK, Germany, France, China, Japan, India, and Brazil. North America accounted for the largest share of the global STD diagnostic market followed by Europe. This growth is attributed due to rising awareness related to health care in this region. Moreover, STD diagnostics market has the huge opportunity in the emerging markets of Asia Pacific due to increasing standard of living, large patient base in this region. However, the Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, due to the rising incidence of sexually transmitted diseases, increasing government support, and growing upper middle-class population and rise in disposable income levels in this region.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global STD diagnostics market include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, bioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure.
[/wptab]
[wptab name=’Table of content’]
- Chapter 1. Introduction
- 1.1. Report Description And Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Global STD Diagnostics Market, 2015 – 2021 (USD Billion)
- 2.2. Global STD Diagnostics Market: Snapshot
- Chapter 3. STD Diagnostics – Market Dynamics
- 3.1. Introduction
- 3.2. Value Chain Analysis
- 3.3. Market Drivers
- 3.3.1. Global STD Diagnostics Market Drivers: Impact Analysis
- 3.3.2. Rapid Spread Of Human Papilloma Virus (HPV) Infection
- 3.3.3. Having Multiple Sex Partners
- 3.4. Market Restraints
- 3.4.1. Global STD Diagnostics Market Restraints: Impact Analysis
- 3.4.2. Lack Of Education Regarding The Prevalence Of STD Problem
- 3.5. Opportunities
- 3.5.1. Covering Untapped Market
- 3.6. Porter’s Five Forces Analysis
- 3.6.1. Bargaining Power Of Suppliers
- 3.6.2. Bargaining Power Of Buyers
- 3.6.3. Threat From New Entrants
- 3.6.4. Threat From New Substitutes
- 3.6.5. Degree Of Competition
- 3.7. Market Attractiveness Analysis
- 3.7.1. Market Attractiveness Analysis, By Type Segment
- 3.7.2. Market Attractiveness Analysis, By End- User Segment
- 3.7.3. Market Attractiveness Analysis, By Testing Device Segment
- 3.7.4. Market Attractiveness Analysis, By Regional Segment
- Chapter 4. Global STD Diagnostics Market – Competitive Landscape
- 4.1. Company Market Share, 2015 (Subject To Data Availability)
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Type Launch
- 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
- 4.2.4. Research And Development, Regional Expansion
- 4.3. Type Portfolio
- Chapter 5. Global STD Diagnostics Market – Test Analysis
- 5.1. Global STD Diagnostics Market: Test Overview
- 5.1.1. Global STD Diagnostics Market Revenue Share, By Test , 2015 And 2021
- 5.2. Chlamydia Testing
- 5.2.1. Global Chlamydia Testing Market, 2015 – 2021 (USD Billion)
- 5.3. Syphilis Testing
- 5.3.1 Global Syphilis Testing Market, 2015 – 2021 (USD Billion)
- 5.4. Gonorrhea Testing
- 5.4.1. Global Gonorrhea Testing Market, 2015 – 2021 (USD Billion)
- 5.5. Herpes Simplex Virus Testing
- 5.5.1. Global Herpes Simplex Virus Testing Market, 2015 – 2021 (USD Billion)
- 5.6. Human Papilloma Virus Testing
- 5.6.1. Global Human Papilloma Virus Testing Market, 2015 – 2021 (USD Billion)
- 5.7. Human Immunodeficiency Virus Testing
- 5.7.1 Global Human Immunodeficiency Virus Testing Market, 2015 – 2021 (USD Billion)
- 5.8. Others
- 5.8.1. Global Other STD Diagnostics Market, 2015 – 2021 (USD Billion)
- 5.1. Global STD Diagnostics Market: Test Overview
- Chapter 6. Global STD Diagnostics Market – End- Users Analysis
- 6.1. Global STD Diagnostics Market: End- Users Segment Overview
- 6.1.1. Global STD Diagnostics Market Revenue Share, By End- Users, 2015 And 2021
- 6.2. Hospitals
- 6.2.1. Global STD Diagnostics Market For Hospitals , 2015 – 2021 (USD Billion)
- 6.3. Others
- 6.3.1. Global STD Diagnostics For Others End- Users Market, 2015 – 2021 (USD Billion)
- 6.1. Global STD Diagnostics Market: End- Users Segment Overview
- Chapter 7. Global STD Diagnostics Market – Testing Device Analysis
- 7.1. Global STD Diagnostics Market: Testing Device Segment Overview
- 7.1.1. Global STD Diagnostics Market Revenue Share, By Testing Device, 2015 And 2021
- 7.2. Laboratory Devices
- 7.2.1. Global STD Diagnostics Market For Laboratory Devices, 2015 – 2021 (USD Billion)
- 7.3. Point Of Care Device
- 7.3.1. Global STD Diagnostics For Point Of Care Device Market, 2015 – 2021 (USD Billion)
- 7.1. Global STD Diagnostics Market: Testing Device Segment Overview
- Chapter 8. Global STD Diagnostics Market – Regional Segment Analysis
- 8.1. Global STD Diagnostics Market: Regional Overview
- 8.1.1. Global STD Diagnostics Market Revenue Share, By Region, 2015 And 2021
- 8.2. North America
- 8.2.1. North America STD Diagnostics Market Revenue, By Type , 2015 – 2021 , (USD Billion)
- 8.2.2. North America STD Diagnostics Market Revenue, By End- User, 2015 – 2021 , (USD Billion)
- 8.2.3. North America STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021 , (USD Billion)
- 8.2.4. U.S.
- 8.2.4.1. U.S. STD Diagnostics Market Revenue, By Type , 2015 – 2021 (USD Billion)
- 8.2.5. U.S.
- 8.2.5.1. U.S. STD Diagnostics Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
- 8.2.6. U.S.
- 8.2.6.1. U.S. STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe STD Diagnostics Market Revenue, By Type , 2015 – 2021 (USD Billion)
- 8.3.2. Europe STD Diagnostics Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
- 8.3.3. Europe STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021 (USD Billion)
- 8.3.4. Germany
- 8.3.4.1. Germany STD Diagnostics Market Revenue, By Type , 2015 – 2021, (USD Billion)
- 8.3.4.2. Germany STD Diagnostics Market Revenue, By End- Users, 2015 – 2021, (USD Billion)
- 8.3.4.3. Germany STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021, (USD Billion)
- 8.3.5. France
- 8.3.5.1. France STD Diagnostics Market Revenue, By Type , 2015 – 2021, (USD Billion)
- 8.3.5.2. France STD Diagnostics Market Revenue, By End- Users, 2015 – 2021, (USD Billion)
- 8.3.5.3. France STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021, (USD Billion)
- 8.3.6. UK
- 8.3.6.1. UK STD Diagnostics Market Revenue, By Type , 2015 – 2021 (USD Billion)
- 8.3.6.2. UK STD Diagnostics Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
- 8.3.6.3. UK STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific STD Diagnostics Market Revenue, By Type , 2015 – 2021 (USD Billion)
- 8.4.2. Asia Pacific STD Diagnostics Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
- 8.4.3. Asia Pacific STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021 (USD Billion)
- 8.4.4. China
- 8.4.4.1. China STD Diagnostics Market Revenue, By Type , 2015 – 2021 (USD Billion)
- 8.4.4.2. China STD Diagnostics Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
- 8.4.4.3. China STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021 (USD Billion)
- 8.4.5. Japan
- 8.4.5.1. Japan STD Diagnostics Market Revenue, By Type , 2015 – 2021 (USD Billion)
- 8.4.5.2. Japan STD Diagnostics Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
- 8.4.5.3. Japan STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021 (USD Billion)
- 8.4.6. India
- 8.4.6.1. India STD Diagnostics Market Revenue, By Type , 2015 – 2021 (USD Billion)
- 8.4.6.2. India STD Diagnostics Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
- 8.4.6.3. India STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America STD Diagnostics Market Revenue, By Type , 2015 – 2021 (USD Billion)
- 8.5.2. Latin America STD Diagnostics Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
- 8.5.3. Latin America STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021 (USD Billion)
- 8.5.4. Brazil
- 8.5.4.1. Brazil STD Diagnostics Market Revenue, By Type , 2015 – 2021 (USD Billion)
- 8.5.4.2. Brazil STD Diagnostics Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
- 8.5.4.3. Brazil STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021 (USD Billion)
- 8.6. Middle East And Africa
- 8.6.1. Middle East And Africa STD Diagnostics Market Revenue, By Type , 2015 – 2021 (USD Billion)
- 8.6.2. Middle East And Africa STD Diagnostics Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
- 8.6.3. Middle East And Africa STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021 (USD Billion)
- 8.1. Global STD Diagnostics Market: Regional Overview
- Chapter 9. Company Profile
- 9.1. Roche Holdings AG
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. Abbott Laboratories
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. Becton Dickinson and Company
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. Hologic Inc.
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. Danaher Corporation
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Developments
- 9.6. Affymetrix
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Developments
- 9.7. bioMerieux
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Developments
- 9.8. Cepheid Inc.
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Developments
- 9.9. Alere Inc.
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Developments
- 9.10. DiaSorin
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Developments
- 9.11. Orasure
- 9.11.1. Overview
- 9.11.2. Financials
- 9.11.3. Product Portfolio
- 9.11.4. Business Strategy
- 9.11.5. Recent Developments
- 9.1. Roche Holdings AG
List of Figures
1. Market Research Process
2. Market Research Methodology
3. Global STD Diagnostics Market Revenue, 2015 – 2021 (USD Billion)
4. Porter’s Five Forces Analysis
5. STD Diagnostics : Market Attractiveness Analysis, By Type Segment
6. STD Diagnostics : Market Attractiveness Analysis, By End- Users Segment
7. STD Diagnostics : Market Attractiveness Analysis, By Testing Device Segment
8. STD Diagnostics : Market Attractiveness Analysis, By Regional Segment
9. Company Market Share Analysis, 2015 And 2021
10. Global STD Diagnostics Market Revenue Share By Type , 2015 And 2021
11. Chlamydia Testing Market, 2015 – 2021, (USD Billion)
12. Syphilis Testing Market, 2015 – 2021, (USD Billion)
13. Gonorrhea Testing Market, 2015 – 2021, (USD Billion)
14. Herpes Simplex Virus Testing Market, 2015 – 2021, (USD Billion)
15. Human Papilloma Virus Testing Market, 2015 – 2021, (USD Billion)
16. Human Immunodeficiency Virus Testing Market, 2015 – 2021, (USD Billion)
17. Other STD Diagnostics Market, 2015 – 2021, (USD Billion)
18. Global STD Diagnostics Market Revenue Share By End- Users, 2015 And 2021
19. STD Diagnostics Market for Hospitals, 2015 – 2021, (USD Billion)
20. STD Diagnostics Market for Other End- Users, 2015 – 2021, (USD Billion)
21. Global STD Diagnostics Market Revenue Share By Testing Device, 2015 And 2021
22. STD Diagnostics Market for Laboratory Devices, 2015 – 2021, (USD Billion)
23. STD Diagnostics Market for Point of Care Device, 2015 – 2021, (USD Billion)
24. Global STD Diagnostics Market Share, By Region, 2015 – 2021
25. North America STD Diagnostics Market, 2015 – 2021, (USD Billion)
26. U.S. STD Diagnostics Market, 2015 – 2021, (USD Billion)
27. Europe STD Diagnostics Market, 2015 – 2021, (USD Billion)
28. UK STD Diagnostics Market, 2015 – 2021, (USD Billion)
29. France STD Diagnostics Market, 2015 – 2021, (USD Billion)
30. Germany STD Diagnostics Market, 2015 – 2021, (USD Billion)
31. Asia Pacific STD Diagnostics Market, 2015 – 2021, (USD Billion)
32. China STD Diagnostics Market, 2015 – 2021, (USD Billion)
33. Japan STD Diagnostics Market, 2015 – 2021, (USD Billion)
34. India STD Diagnostics Market, 2015 – 2021, (USD Billion)
35. Latin America STD Diagnostics Market, 2015-2021, (USD Billion)
36. Brazil STD Diagnostics Market, 2015 – 2021, (USD Billion)
37. Middle East & Africa STD Diagnostics Market, 2015 – 2021, (USD Billion)
List of Tables
1. STD Diagnostics Market: Market Snapshot
2. Drivers Of Global STD Diagnostics Market: Impact Analysis
3. Restraints Of Global STD Diagnostics Market: Impact Analysis
4. North America STD Diagnostics Market Revenue, By Type , 2015 – 2021(USD Billion)
5. North America STD Diagnostics Market Revenue, By End- Users, 2015 – 2021(USD Billion)
6. North America STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021(USD Billion)
7. US STD Diagnostics Market Revenue, By Type , 2015 – 2021(USD Billion)
8. US STD Diagnostics Market Revenue, By End- Users, 2015 – 2021(USD Billion)
9. US STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021(USD Billion)
10. Europe STD Diagnostics Market Revenue, By Type , 2015 – 2021(USD Billion)
11. Europe STD Diagnostics Market Revenue, By End- Users, 2015 – 2021(USD Billion)
12. Europe STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021(USD Billion)
13. UK STD Diagnostics Market Revenue, By Type , 2015 – 2021(USD Billion)
14. UK STD Diagnostics Market Revenue, By End- Users, 2015 – 2021(USD Billion)
15. UK STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021(USD Billion)
16. France STD Diagnostics Market Revenue, By Type , 2015 – 2021(USD Billion)
17. France STD Diagnostics Market Revenue, By End- Users, 2015 – 2021(USD Billion)
18. France STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021(USD Billion)
19. Germany STD Diagnostics Market Revenue, By Type , 2015 – 2021(USD Billion)
20. Germany STD Diagnostics Market Revenue, By End- Users, 2015 – 2021(USD Billion)
21. Germany STD Diagnostics Market Revenue, By Testing Device , 2015 – 2021(USD Billion)
22. Asia Pacific STD Diagnostics Market Revenue, By Type 2015 – 2021(USD Billion)
23. Asia Pacific STD Diagnostics Market Revenue, By End- Users 2015 – 2021(USD Billion)
24. Asia Pacific STD Diagnostics Market Revenue, By Testing Device 2015 – 2021(USD Billion)
25. Latin America STD Diagnostics Market Revenue, By Type – 2021 (USD Billion)
26. Latin America STD Diagnostics Market Revenue, By End- Users – 2021 (USD Billion)
27. Latin America STD Diagnostics Market Revenue, By Testing Device – 2021 (USD Billion)
28. Brazil STD Diagnostics Market Revenue, By Type – 2021 (USD Billion)
29. Brazil STD Diagnostics Market Revenue, By End- Users – 2021 (USD Billion)
30. Brazil STD Diagnostics Market Revenue, By Testing Device – 2021 (USD Billion)
31. Middle East And Africa STD Diagnostics Market Revenue, By Type – 2021 (USD Billion)
32. Middle East And Africa STD Diagnostics Market Revenue, By End- Users – 2021 (USD Billion)
33. Middle East And Africa STD Diagnostics Market Revenue, By Testing Device – 2021 (USD Billion)
[/wptab]
[wptab name=’Request For Sample’]
[/wptab]
[end_wptabset]